nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adverse event management in the TOURMALINE-MM3 study of post-transplant ixazomib maintenance in multiple myeloma
|
Kaiser, Martin |
|
|
99 |
8 |
p. 1793-1804 |
artikel |
2 |
An eleven-year cohort of bloodstream infections in 552 febrile neutropenic patients: resistance profiles of Gram-negative bacteria as a predictor of mortality
|
Kara Ali, Ritvan |
|
|
99 |
8 |
p. 1925-1932 |
artikel |
3 |
Bone turnover markers as an aid to monitor osteoporosis following allogeneic hematopoietic stem cell transplantation
|
Kurosawa, Shuhei |
|
|
99 |
8 |
p. 1873-1882 |
artikel |
4 |
Chimeric antigen receptor therapy in hematological malignancies: antigenic targets and their clinical research progress
|
Zhao, Juanjuan |
|
|
99 |
8 |
p. 1681-1699 |
artikel |
5 |
Clinical characteristics and treatment outcome of type I cryoglobulinemia in Chinese patients: a single-center study of 45 patients
|
Zhang, Le-le |
|
|
99 |
8 |
p. 1735-1740 |
artikel |
6 |
COVID-19-driven endothelial damage: complement, HIF-1, and ABL2 are potential pathways of damage and targets for cure
|
Marchetti, Monia |
|
|
99 |
8 |
p. 1701-1707 |
artikel |
7 |
COVID-19, impact on myeloma patients
|
Dufour, Inès |
|
|
99 |
8 |
p. 1947-1949 |
artikel |
8 |
COVID-19 presenting as neutropenic fever
|
Spencer, Hunter C. |
|
|
99 |
8 |
p. 1939-1940 |
artikel |
9 |
De-escalation of empiric broad spectrum antibiotics in hematopoietic stem cell transplant recipients with febrile neutropenia
|
Rearigh, Lindsey |
|
|
99 |
8 |
p. 1917-1924 |
artikel |
10 |
Detection of the MYD88L265P and CXCR4S338X mutations by cell-free DNA in Waldenström macroglobulinemia
|
Wu, Yan-Yan |
|
|
99 |
8 |
p. 1763-1769 |
artikel |
11 |
Fatal SARS-CoV-2 coinfection in course of EBV-associated lymphoproliferative disease
|
Roncati, Luca |
|
|
99 |
8 |
p. 1945-1946 |
artikel |
12 |
Gene mutation profile in patients with acquired pure red cell aplasia
|
Long, Zhangbiao |
|
|
99 |
8 |
p. 1749-1754 |
artikel |
13 |
Impact of central nervous system (CNS) prophylaxis on the incidence of CNS relapse in patients with high-risk diffuse large B cell/follicular grade 3B lymphoma
|
Kuitunen, Hanne |
|
|
99 |
8 |
p. 1823-1831 |
artikel |
14 |
Long-term follow-up of a novel immunosuppressive strategy of cyclosporine alternatively combined with levamisole for severe aplastic anemia
|
Huo, Jiali |
|
|
99 |
8 |
p. 1727-1734 |
artikel |
15 |
Long-term survival and polyclonal immunoglobulin reconstitution after allogeneic stem cell transplantation in multiple myeloma
|
Eisfeld, Christine |
|
|
99 |
8 |
p. 1907-1915 |
artikel |
16 |
Measures for preventing nosocomial infection with SARS-CoV-2 in hematology departments
|
Wang, Yingying |
|
|
99 |
8 |
p. 1933-1938 |
artikel |
17 |
Measuring the cellular memory B cell response after vaccination in patients after allogeneic stem cell transplantation
|
Winkler, Julia |
|
|
99 |
8 |
p. 1895-1906 |
artikel |
18 |
Monosomal karyotype is associated with poor outcomes in patients with Philadelphia chromosome–negative acute lymphoblastic leukemia receiving chemotherapy but not allogeneic hematopoietic stem cell transplantation
|
Li, Zongru |
|
|
99 |
8 |
p. 1833-1843 |
artikel |
19 |
Necrotizing fasciitis in haematological patients: a different scenario
|
Albasanz-Puig, A. |
|
|
99 |
8 |
p. 1741-1747 |
artikel |
20 |
Outcomes of allogeneic haematopoietic stem cell transplantation for patients with severe aplastic anaemia using the porcine antilymphocyte globulin-containing conditioning regimen
|
Li, Lin |
|
|
99 |
8 |
p. 1863-1871 |
artikel |
21 |
Pre-transplant FLT3/ITD status predicts outcome in FLT3-mutated acute myeloid leukemia following allogeneic stem cell transplantation
|
Helbig, Grzegorz |
|
|
99 |
8 |
p. 1845-1853 |
artikel |
22 |
Recurrence of immune thrombocytopenia at the time of SARS-CoV-2 infection
|
Merli, Michele |
|
|
99 |
8 |
p. 1951-1952 |
artikel |
23 |
Risk and impact of invasive fungal infections in patients with multiple myeloma
|
Tsai, Chun-Kuang |
|
|
99 |
8 |
p. 1813-1822 |
artikel |
24 |
Risk factors and associations with clinical outcomes of cytomegalovirus reactivation after haploidentical versus matched-sibling unmanipulated PBSCT in patients with hematologic malignancies
|
Gao, Xiao-Ning |
|
|
99 |
8 |
p. 1883-1893 |
artikel |
25 |
Safety and efficacy of temsirolimus in combination with three different immuno-chemotherapy regimens in relapse and refractory mantle cell lymphoma, final results of the T3 phase IB trial of the LYSA
|
Tessoulin, Benoît |
|
|
99 |
8 |
p. 1771-1778 |
artikel |
26 |
Safety of bedside lumbar puncture in adult patients with thrombocytopenia
|
Portuguese, Andrew Jay |
|
|
99 |
8 |
p. 1755-1762 |
artikel |
27 |
SARS-CoV-2-associated cold agglutinin disease: a report of two cases
|
Huscenot, Tessa |
|
|
99 |
8 |
p. 1943-1944 |
artikel |
28 |
SARS-CoV-2 infection in children with febrile neutropenia
|
Flores, Victoria |
|
|
99 |
8 |
p. 1941-1942 |
artikel |
29 |
Sequential allogeneic hematopoietic stem cell transplantation for active refractory/relapsed myeloid malignancies: results of a reduced-intensity conditioning preceded by clofarabine and cytosine arabinoside, a retrospective study on behalf of the SFGM-TC
|
Le Bourgeois, Amandine |
|
|
99 |
8 |
p. 1855-1862 |
artikel |
30 |
Serum-free light chains combined with the Revised International Staging System could further distinguish the superior and inferior clinical outcome of multiple myeloma patients
|
Du, Juan |
|
|
99 |
8 |
p. 1779-1791 |
artikel |
31 |
Statin use and the risk of multiple myeloma: a PRISMA-compliant meta-analysis
|
Zhang, Pengcheng |
|
|
99 |
8 |
p. 1805-1812 |
artikel |
32 |
The clinical management of lenalidomide-based therapy in patients with newly diagnosed multiple myeloma
|
Merz, Maximilian |
|
|
99 |
8 |
p. 1709-1725 |
artikel |